Exploring Patient-Reported Costs Related to Hepatitis C on the Medical Crowdfunding Page GoFundMe®

T Joseph Mattingly1, Karen Li2, Arnold Ng2

  • 1Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, Room 224, Baltimore, MD, 21201, USA. jmattingly@rx.umaryland.edu.

Pharmacoeconomics - Open
|September 30, 2020
PubMed

Insights

Disclosing the source of Hepatitis C virus (HCV) infection on GoFundMe pages was linked to increased donations. Patients seeking medical crowdfunding may benefit from sharing their infection source.

Area of Science:

  • Medical Crowdfunding
  • Hepatitis C Virus (HCV) Infection
  • Public Health

Background:

  • Medical crowdfunding platforms like GoFundMe can help offset significant healthcare costs.
  • Hepatitis C virus (HCV) is often associated with social stigma, potentially impacting fundraising success.
  • Understanding factors influencing crowdfunding success is crucial for patients managing expensive medical bills.

Purpose of the Study:

  • To analyze characteristics of successful GoFundMe campaigns for Hepatitis C virus (HCV) patients.
  • To investigate the association between disclosed HCV infection sources and donation amounts.
  • To identify patterns in patient-reported costs for medical fundraising.

Main Methods:

  • A pilot cross-sectional study analyzed 685 publicly available GoFundMe pages for HCV patients (June 2019).
  • Data extracted included disclosure of HCV infection source, reported cause of infection, and requested funds.
  • Donation amounts were categorized as small (<$1000), moderate ($1000-$4999), and large (≥$5000); exploratory analyses were performed.

Main Results:

  • Only 30% of pages disclosed the HCV infection source; 86% of these cited socially desirable causes (e.g., blood transfusion).
  • Donation amounts varied: 46% received <$1000, 38% received $1000-$4999, and 16% received ≥$5000.
  • Disclosure of the virus source was significantly associated with higher donation categories (p=0.0099).

Conclusions:

  • Disclosing the source of Hepatitis C virus infection may positively influence medical crowdfunding outcomes.
  • Findings offer insights for patients and caregivers utilizing crowdfunding for medical expenses.
  • The study highlights the need for further research into self-reported costs in public medical fundraising requests.
Abstract

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...